Dai Rongjuan, Peng Feng, Xiao Xinqiang, Gong Xing, Jiang Yongfang, Zhang Min, Tian Yi, Xu Yun, Ma Jing, Li Mingming, Luo Yue, Gong Guozhong
Department of Infectious Diseases, Institute of Hepatology Central South University, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, PR China.
Oncotarget. 2017 May 5;8(37):60962-60974. doi: 10.18632/oncotarget.17631. eCollection 2017 Sep 22.
The HBx protein of hepatitis B virus (HBV) is widely recognized to be a critical oncoprotein contributing to the development of HBV-related hepatocellular carcinoma (HCC). In addition, cationic amino acid transporter 1 (CAT-1) gene is a target of miR-122. In this study, we found that CAT-1 protein levels were higher in HBV-related HCC carcinomatous tissues than in para-cancerous tumor tissues, and that CAT-1 promoted HCC cell growth, proliferation, and metastasis. Moreover, HBx-induced decreases in Gld2 and miR-122 levels that contributed to the upregulation of CAT-1 in HCC. These results indicate that a Gld2/miR-122/CAT-1 pathway regulated by HBx likely participates in HBV-related hepatocellular carcinogenesis.
乙型肝炎病毒(HBV)的X蛋白(HBx)被广泛认为是一种关键的癌蛋白,在HBV相关肝细胞癌(HCC)的发生发展中起作用。此外,阳离子氨基酸转运体1(CAT-1)基因是miR-122的一个靶点。在本研究中,我们发现,与癌旁组织相比,CAT-1蛋白水平在HBV相关HCC癌组织中更高,并且CAT-1促进HCC细胞生长、增殖和转移。此外,HBx诱导的Gld2和miR-122水平降低导致了HCC中CAT-1的上调。这些结果表明,由HBx调控的Gld2/miR-122/CAT-1通路可能参与了HBV相关肝细胞癌的发生。